'Omics' and endocrine-disrupting chemicals - new paths forward

Area of Science:

• Environmental Health Sciences
• Genomics
• Toxicology

Background:

• Endocrine-disrupting chemicals (EDCs) pose risks, but understanding their impact is limited.
• Research is hindered by challenges in exposure assessment and identifying sensitive outcomes.
• Current knowledge gaps impede effective EDC risk management and public health strategies.

Purpose of the Study:

• To explore the potential of omics technologies in advancing endocrine-disrupting chemical (EDC) research.
• To enhance exposure assessment by incorporating the exposome concept.
• To improve the prediction of individual health risks and susceptibility to EDCs.

Main Methods:

• Leveraging genomics, epigenomics, and mitochondriomics for comprehensive biological data generation.
• Integrating omics data to characterize the exposome and estimate lifetime exposure burden.
• Applying omics-driven insights to predict individual variability and disease response.

Main Results:

• Omics technologies can generate data to significantly enhance exposure assessment.
• These technologies provide biology-based estimates of individual risks and susceptibility.
• Advancements in omics facilitate a deeper understanding of EDC impact on health.

Conclusions:

• Omics technologies are crucial for bridging knowledge gaps in endocrine-disrupting chemical (EDC) research.
• Refined exposure characterization and risk prediction pave the way for precision public health.
• Integrating omics will transform EDC research and inform targeted public health interventions.